Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hypoxia-inducible factor 1-alpha (HIF-1α) is a subunit of the heterodimeric transcription factor hypoxia-inducible factor 1 (HIF-1), encoded by the HIF1A gene. It is considered the master regulator of cellular and developmental responses to hypoxia, or low oxygen conditions. HIF-1α plays a central role in regulating genes involved in angiogenesis, energy metabolism, cell survival, tumor invasion, and vascularization.
Currently under research. Several compounds are being developed to inhibit HIF-1α or its downstream targets, aiming to disrupt the pathways that promote tumor growth, angiogenesis, and metastasis. Inhibition typically involves destabilizing HIF-1α, interfering with its dimerization with ARNT/HIF-1β, or blocking its ability to bind to hypoxia-responsive elements (HREs).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hypoxia-inducible factor 1-alpha (HIF-1α).